Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZP-Glucagon vs Injectable Glucagon for Insulin-Induced Hypoglycemia in T1D
NCT02459938Phase 1Completed
- Sponsor
- Zosano Pharma
- Start
- Jan 2015
- Primary completion
- Aug 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of biochaperone glucagon in hypoglycemia (4 arms), sponsored by Zosano Pharma. Primary endpoint: Percentage of subjects achieving normoglycemia at 30 minutes. Started Jan 2015; status: completed.
02
Drugs
biochaperone glucagon
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT02459938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02459938.